Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
63.3M
-
Shares change
-
-5.02M
-
Total reported value, excl. options
-
$2.6B
-
Value change
-
-$178M
-
Put/Call ratio
-
0.31
-
Number of buys
-
114
-
Number of sells
-
-131
-
Price
-
$41.10
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2017
297 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q4 2017.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.3M shares
of 115M outstanding shares and own 54.94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.8M shares), WELLINGTON MANAGEMENT GROUP LLP (6.7M shares), Vanguard Group Inc (5.94M shares), JANUS HENDERSON GROUP PLC (3.48M shares), STATE STREET CORP (2.5M shares), Bank of New York Mellon Corp (1.86M shares), DIMENSIONAL FUND ADVISORS LP (1.75M shares), Standard Life Aberdeen plc (1.72M shares), Van Berkom & Associates Inc. (1.52M shares), and ROYAL BANK OF CANADA (1.3M shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.